Underprescribing in Geriatric Patients: a Prevalence Study and Analysis of Factors Contributing to Potential Prescription Omissions (Under-PRES)
Under-PRES
1 other identifier
observational
374
1 country
2
Brief Summary
This observational study will determine the prevalence of underprescription in a cohort of elderly patients, recruited at the time of an outpatient geriatric visit, or hospitalized, upon admission to a geriatric ward.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2024
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 20, 2024
CompletedFirst Submitted
Initial submission to the registry
March 25, 2025
CompletedFirst Posted
Study publicly available on registry
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
April 1, 2025
March 1, 2025
2.5 years
March 25, 2025
March 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of potential prescription omissions (PPOs)
Prevalence of potential prescription omissions (PPOs) will be evaluated by Screening Tool to Alert doctors to Right Treatment (START) criteria version 3 in aged patients enrolled on admission to geriatric departments of participating centers or during geriatric outpatient clinic visits
at baseline and 3 months later
Secondary Outcomes (1)
Characterisation of the potential prescription omissions (PPOs)
at baseline and 3 months later
Study Arms (1)
older adults
Geriatric patients admitted to a geriatric hospital unit or attending an outpatient geriatric clinic
Eligibility Criteria
Older patients at admission to a geriatric ward or at the time of outpatient geriatric visits
You may qualify if:
- Geriatric ward admission or outpatient geriatric appointment
- Capacity to provide informed consent by the patient or legal guardian
You may not qualify if:
- Limited life expectancy as measured by the Clinical Frailty Scale (CFS) \>8
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
IRCCS INRCA Hospital
Ancona, 60127, Italy
IRCCS INRCA Hospital
Cosenza, 87100, Italy
Study Officials
- STUDY CHAIR
Antonio Cherubini, MD
IRCCS INRCA, Ancona, Italy
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 25, 2025
First Posted
April 1, 2025
Study Start
June 20, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
April 1, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share